21 May 2013
Keywords: mgi, pharma, initiates, ph, iii, aquavan, program
Article | 27 March 2006
MGI Pharma, an oncology and acute care-focused US biopharmaceutical company, has inititated a pivotal Phase III program of its
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 March 2006
20 March 2006
20 May 2013
© 2013 thepharmaletter.com